261 related articles for article (PubMed ID: 28570977)
41. Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
[TBL] [Abstract][Full Text] [Related]
42. Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors.
Amr AEE; Abo-Ghalia MH; Moustafa GO; Al-Omar MA; Nossier ES; Elsayed EA
Molecules; 2018 Sep; 23(10):. PubMed ID: 30241374
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.
Liu YQ; Li XJ; Zhao CY; Nan X; Tian J; Morris-Natschke SL; Zhang ZJ; Yang XM; Yang L; Li LH; Zhou XW; Lee KH
Bioorg Med Chem; 2013 Mar; 21(5):1248-56. PubMed ID: 23369687
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents.
Yang SJ; Liu MC; Zhao Q; Hu DY; Xue W; Yang S
Eur J Med Chem; 2015; 96():58-65. PubMed ID: 25874331
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.
Xie W; Xie S; Zhou Y; Tang X; Liu J; Yang W; Qiu M
Eur J Med Chem; 2014 Jun; 81():22-7. PubMed ID: 24819956
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis and biological evaluation of novel asperphenamate derivatives.
Liu Q; Li W; Sheng L; Zou C; Sun H; Zhang C; Liu Y; Shi J; Ma E; Yuan L
Eur J Med Chem; 2016 Mar; 110():76-86. PubMed ID: 26807546
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents.
Li D; Liu H; Liu Y; Zhang Q; Liu C; Zhao S; Jiao B
Bioorg Med Chem Lett; 2017 Feb; 27(3):533-536. PubMed ID: 28057423
[TBL] [Abstract][Full Text] [Related]
50. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
51. Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
Han T; Tian K; Pan H; Liu Y; Xu F; Li Z; Uchita T; Gao M; Hua H; Li D
Eur J Med Chem; 2018 Apr; 150():53-63. PubMed ID: 29524728
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.
Fu W; Wang J; Yu L; Zhao L; Lu N; You Q; Guo Q; Li Z
Bioorg Med Chem Lett; 2012 Jan; 22(2):1118-21. PubMed ID: 22196122
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and antiproliferative activity of thiazolo[5,4-d]pyrimidine derivatives through the atom replacement strategy.
Li ZH; Liu XQ; Geng PF; Zhang J; Ma JL; Wang B; Zhao TQ; Zhao B; Zhang XH; Yu B; Liu HM
Eur J Med Chem; 2017 Sep; 138():1034-1041. PubMed ID: 28759876
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and antiproliferative activity of novel 2,4-diamino-5-methyleneaminopyrimidine derivatives as potential anticancer agents.
Li Q; Chen L; Jian XE; Lv DX; You WW; Zhao PL
Bioorg Med Chem Lett; 2021 Sep; 47():128213. PubMed ID: 34157389
[TBL] [Abstract][Full Text] [Related]
55. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
Gonçalves BM; Salvador JA; Marín S; Cascante M
Eur J Med Chem; 2016 May; 114():101-17. PubMed ID: 26974379
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, structure-activity relationship studies and biological evaluation of novel 2,5-disubstituted indole derivatives as anticancer agents.
Hu H; Wu J; Ao M; Wang H; Zhou T; Xue Y; Qiu Y; Fang M; Wu Z
Chem Biol Drug Des; 2016 Nov; 88(5):766-778. PubMed ID: 27315790
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
Yugandhar D; Nayak VL; Archana S; Shekar KC; Srivastava AK
Eur J Med Chem; 2015 Aug; 101():348-57. PubMed ID: 26163220
[TBL] [Abstract][Full Text] [Related]
59. Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.
Yue B; Zhao CR; Xu HM; Li YY; Cheng YN; Ke HN; Yuan Y; Wang RQ; Shi YQ; Lou HX; Qu XJ
Biochim Biophys Acta; 2013 Jan; 1830(1):2194-203. PubMed ID: 23085067
[TBL] [Abstract][Full Text] [Related]
60. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]